RARRES1 and cancer: In concurrence with previous reports examining various human cancers [2]–[4], [6]–[8], [27], we observed that re-expression of RARRES1 not only augmented cell death induced by cytotoxic agents Paclitaxel and Doxorubicin (Figure 6B), but also impeded cell invasion (upper panel of Figure 6C).